Clinical trials
Enrolling by invitation Observational Liver Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2018 | 2 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Enrolling by invitation | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Tsinghua Chang Gung Hospital | 1 |
| Gene Solutions | 1 |
| National Cancer Center, Korea | 1 |
| National Cancer Institute (NCI) | 1 |
| Prof. Valérie Mc Lin | 1 |
| University of Molise | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Neoplasms | 6 |
| Lung Neoplasms | 2 |
| Breast Neoplasms | 1 |
| Carcinoma, Hepatocellular | 1 |
| Colonic Neoplasms | 1 |
| Congenital Portosystemic Shunt | 1 |
| Gastrointestinal Neoplasms | 1 |
| Hematologic Neoplasms | 1 |
| Hepatic Encephalopathy | 1 |
| Hepatopulmonary Syndrome | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.